CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market buy Director bought 2,000 shares at $13.65 ($27,300)
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Open-market buy Director bought 1,298,701 shares at $19.25 ($24,999,994)
- 4/A Open-market sale 10% owner sold 1,298,701 shares at $19.25 ($24,999,994)
- 4 Open-market sale 10% owner sold 1,298,701 shares at $19.25 ($24,999,994)
- 4 Open-market buy Director bought 2,090 shares at $14.77 ($30,863)
- 4 Open-market sale See Remarks sold 2,612 shares at $13.53 ($35,352)
- 4 Open-market buy Director bought 40,562 shares at $19.25 ($780,819)
- 4 Open-market buy Director bought 628,536 shares at $19.25 ($12,099,318)
- 4 Open-market sale 10% owner sold 5,307,940 shares at $19.25 ($102,177,845)
- 8-K Event Material agreement
- 424B4 Offering Prospectus
Page 22 of 28 · 558 filings